BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND TCEA1, ENSG00000187735, 6917
7 results:

  • 1. Risk model based on genes regulating the response of tumor cells to T-cell-mediated killing in esophageal squamous cell carcinoma.
    Zhang X; Yu C; Zhou S; Zhang Y; Tian B; Bian Y; Wang W; Lin H; Wang LW
    Aging (Albany NY); 2024 Feb; 16(3):2494-2516. PubMed ID: 38305770
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Euphorbia tirucalli modulates gene expression in larynx squamous cell carcinoma.
    Franco-Salla GB; Prates J; Cardin LT; Dos Santos AR; Silva WA; da Cunha BR; Tajara EH; Oliani SM; Rodrigues-Lisoni FC
    BMC Complement Altern Med; 2016 May; 16():136. PubMed ID: 27209356
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characteristics and intraoperative treatments associated with head and neck free tissue transfer complications and failures.
    Hand WR; McSwain JR; McEvoy MD; Wolf B; Algendy AA; Parks MD; Murray JL; Reeves ST
    Otolaryngol Head Neck Surg; 2015 Mar; 152(3):480-7. PubMed ID: 25550221
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study.
    Matsuyama A; Hisaoka M; Hashimoto H
    Virchows Arch; 2011 Nov; 459(5):539-45. PubMed ID: 21927843
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.
    Matsuyama A; Hisaoka M; Nagao Y; Hashimoto H
    Virchows Arch; 2011 May; 458(5):583-92. PubMed ID: 21394649
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CHCHD7-PLAG1 and tcea1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas.
    Asp J; Persson F; Kost-Alimova M; Stenman G
    Genes Chromosomes Cancer; 2006 Sep; 45(9):820-8. PubMed ID: 16736500
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR.
    Juweid ME; Hajjar G; Stein R; Sharkey RM; Herskovic T; Swayne LC; Suleiman S; Pereira M; Rubin AD; Goldenberg DM
    J Nucl Med; 2000 Jan; 41(1):93-103. PubMed ID: 10647610
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.